Dr Richard Hansen

  • Honorary Clinical Associate Professor (School of Medicine, Dentistry & Nursing)

Publications

List by: Type | Date

Jump to: 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
Number of items: 28.

2019

Logan, M. et al. (2019) The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Alimentary Pharmacology and Therapeutics, 50(6), pp. 664-674. (doi:10.1111/apt.15425) (PMID:31342536) (PMCID:PMC6772069)

Gerasimidis, K. , Svolos, V., Nichols, B., Papadopoulou, R., Quince, C., Ijaz, U. Z. , Milling, S. , Gaya, D. R., Russell, R. K. and Hansen, R. (2019) Shifting the paradigm of nutritional therapy of Crohn’s disease. Gastroenterology, (Accepted for Publication)

Hansen, R., Gerasimidis, K. and Turner, S. (2019) Asthma causation and the gastrointestinal microbiome and metabolome: might there be a signal, or is it just noise? Journal of Allergy and Clinical Immunology, 144(2), pp. 401-403. (doi:10.1016/j.jaci.2019.04.026) (PMID:31078572)

Ormsby, M. J. et al. (2019) Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli. EBioMedicine, 43, pp. 325-332. (doi:10.1016/j.ebiom.2019.03.071) (PMID:31036531) (PMCID:PMC6557746)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi:10.1053/j.gastro.2018.12.002) (PMID:30550821)

2018

McIlroy, J., Ianiro, G., Mukhopadhya, I., Hansen, R. and Hold, G.L. (2018) Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Alimentary Pharmacology and Therapeutics, 47(1), pp. 26-42. (doi:10.1111/apt.14384) (PMID:29034981)

Richmond, L., Curtis, L., Garrick, V., Rogers, P., Wilson, M., Tayler, R., Henderson, P., Hansen, R., Wilson, D. C. and Russell, R. K. (2018) Biosimilar infliximab use in paediatric IBD. Archives of Disease in Childhood, 103(1), pp. 89-91. (doi:10.1136/archdischild-2017-313404) (PMID:28988215)

2017

Logan, M., Ijaz, U.Z. , Hansen, R., Gerasimidis, K. and Russell, R.K. (2017) Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's Disease. Alimentary Pharmacology and Therapeutics, 46(11-12), pp. 1119-1120. (doi:10.1111/apt.14351) (PMID:29105140)

Ijaz, U. Z. et al. (2017) The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically linked kindred. PLoS ONE, 12(2), e0172605. (doi:10.1371/journal.pone.0172605) (PMID:28222161) (PMCID:PMC5319678)

Svolos, V. et al. (2017) Dietary Manipulation of the Healthy Human and Colitic Murine Gut Microbiome by CD-TREAT Diet and Exclusive Enteral Nutrition; A Proof of Concept Studyy. 12th Congress of ECCO, Barcelona, Spain, 15-18 Feb 2017. S29-S30. (doi:10.1093/ecco-jcc/jjx002.045)

Svolos, V. et al. (2017) Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterology, 17, 14. (doi:10.1186/s12876-016-0564-7) (PMID:28103809) (PMCID:PMC5247812)

2016

Gerasimidis, K. , Ijaz, U. Z. , Edwards, C. , Russell, R. K., Quince, C. and Hansen, R. (2016) Response to Kaakoush et al. American Journal of Gastroenterology, 111(7), pp. 1033-1034. (doi:10.1038/ajg.2016.169) (PMID:27356826)

Svolos, V., Hansen, R., Hughes, K., Ijaz, U.Z. , Quince, C., Gaya, D., Russell, R. and Gerasimidis, K. (2016) The Impact of ‘Crohn’s Disease-TReatment-with-EATing’ Diet (CD-TREAT Diet) and Exclusive Enteral Nutrition on Healthy Gut Bacteria Metabolism. 11th Congress of the European Crohn's and Colitis Organisation, Amsterdam, The Netherlands, 16-19 March 2016. S14-S15. (doi:10.1093/ecco-jcc/jjw019.017)

2015

Quince, C. et al. (2015) Extensive modulation of the fecal metagenome in children with Crohn’s Disease during exclusive enteral nutrition. American Journal of Gastroenterology, 110, pp. 1718-1729. (doi:10.1038/ajg.2015.357) (PMID:26526081)

Hansen, R., Russell, R. K. and Muhammed, R. (2015) Recent advances in paediatric gastroenterology. Archives of Disease in Childhood, 100(9), pp. 886-890. (doi:10.1136/archdischild-2014-307089) (PMID:25710546)

Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J.M., Russell, R.K., Berry, S.H., El-Omar, E.M. and Hold, G.L. (2015) The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes and Infection, 17(4), pp. 304-310. (doi:10.1016/j.micinf.2014.12.001) (PMID:25522934) (PMCID:PMC4392392)

Hansen, R., Scott, K. P., Khan, S., Martin, J. C., Berry, S. H., Stevenson, M., Okpapi, A., Munro, M. J. and Hold, G. L. (2015) First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS ONE, 10(7), e0133320. (doi:10.1371/journal.pone.0133320) (PMID:26218283) (PMCID:PMC4517813)

2014

Adams, A. T. et al. (2014) Two-stage genome-wide methylation profiling in childhood-onset Crohnʼs disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflammatory Bowel Diseases, 20(10), pp. 1784-1793. (doi:10.1097/MIB.0000000000000179) (PMID:25144570)

Gerasimidis, K. , Russell, R., Hansen, R., Quince, C., Loman, N., Bertz, M., Hanske, L., Blaut, M., McGrogan, P. and Edwards, C. A. (2014) Role of Faecalibacterium prausnitzii in Crohnʼs Disease. Inflammatory Bowel Diseases, 20(7), E18-E19. (doi:10.1097/MIB.0000000000000079)

2013

Hansen, R. et al. (2013) The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS ONE, 8(3), e58825. (doi:10.1371/journal.pone.0058825) (PMID:23554935) (PMCID:PMC3595230)

2012

Hansen, R. et al. (2012) Microbiota of de-novo pediatric IBD: increased faecalibacterium prausnitzii and reduced bacterial diversity in crohn's but not in ulcerative colitis. American Journal of Gastroenterology, 107(12), pp. 1913-1922. (doi:10.1038/ajg.2012.335)

Henderson, P. et al. (2012) Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflammatory Bowel Diseases, 18(6), pp. 999-1005. (doi:10.1002/ibd.21797) (PMID:21688352)

Mukhopadhya, I., Hansen, R., El-Omar, E. M. and Hold, G. L. (2012) IBD—what role do proteobacteria play? Nature Reviews Gastroenterology and Hepatology, 9(4), pp. 219-230. (doi:10.1038/nrgastro.2012.14) (PMID:22349170)

2011

Hansen, R., Thomson, J. M., Fox, J. G., El-Omar, E. M. and Hold, G. L. (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunology and Medical Microbiology, 61(1), pp. 1-14. (doi:10.1111/j.1574-695X.2010.00744.x) (PMID:20955468)

Mukhopadhya, I. et al. (2011) A comprehensive evaluation of colonic mucosal isolates of sutterella wadsworthensis from inflammatory bowel disease. PLoS ONE, 6(10), e27076. (doi:10.1371/journal.pone.0027076)

Mukhopadhya, I., Thomson, J. M., Hansen, R., Berry, S. H., El-Omar, E. M. and Hold, G. L. (2011) Detection of campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE, 6(6), e21490. (doi:10.1371/journal.pone.0021490) (PMID:21738679) (PMCID:PMC3124515)

Thomson, J. M. et al. (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS ONE, 6(2), e17184. (doi:10.1371/journal.pone.0017184) (PMID:21383845) (PMCID:PMC3044171)

2010

Hansen, R., Cameron, F. L., Hold, G. L., El-Omar, E. M. and Russell, R. K. (2010) Inflammatory bowel disease. Paediatrics and Child Health, 20(10), pp. 473-478. (doi:10.1016/j.paed.2010.04.005)

This list was generated on Tue Dec 10 02:55:17 2019 GMT.
Number of items: 28.

Articles

Logan, M. et al. (2019) The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Alimentary Pharmacology and Therapeutics, 50(6), pp. 664-674. (doi:10.1111/apt.15425) (PMID:31342536) (PMCID:PMC6772069)

Gerasimidis, K. , Svolos, V., Nichols, B., Papadopoulou, R., Quince, C., Ijaz, U. Z. , Milling, S. , Gaya, D. R., Russell, R. K. and Hansen, R. (2019) Shifting the paradigm of nutritional therapy of Crohn’s disease. Gastroenterology, (Accepted for Publication)

Hansen, R., Gerasimidis, K. and Turner, S. (2019) Asthma causation and the gastrointestinal microbiome and metabolome: might there be a signal, or is it just noise? Journal of Allergy and Clinical Immunology, 144(2), pp. 401-403. (doi:10.1016/j.jaci.2019.04.026) (PMID:31078572)

Ormsby, M. J. et al. (2019) Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli. EBioMedicine, 43, pp. 325-332. (doi:10.1016/j.ebiom.2019.03.071) (PMID:31036531) (PMCID:PMC6557746)

Svolos, V. et al. (2019) Treatment of active Crohn’s disease with an ordinary food-based diet that replicates exclusive enteral nutrition. Gastroenterology, 156(5), 1354-1367.e6. (doi:10.1053/j.gastro.2018.12.002) (PMID:30550821)

McIlroy, J., Ianiro, G., Mukhopadhya, I., Hansen, R. and Hold, G.L. (2018) Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. Alimentary Pharmacology and Therapeutics, 47(1), pp. 26-42. (doi:10.1111/apt.14384) (PMID:29034981)

Richmond, L., Curtis, L., Garrick, V., Rogers, P., Wilson, M., Tayler, R., Henderson, P., Hansen, R., Wilson, D. C. and Russell, R. K. (2018) Biosimilar infliximab use in paediatric IBD. Archives of Disease in Childhood, 103(1), pp. 89-91. (doi:10.1136/archdischild-2017-313404) (PMID:28988215)

Logan, M., Ijaz, U.Z. , Hansen, R., Gerasimidis, K. and Russell, R.K. (2017) Letter: reproducible evidence shows that exclusive enteral nutrition significantly reduces faecal calprotectin concentrations in children with active Crohn's Disease. Alimentary Pharmacology and Therapeutics, 46(11-12), pp. 1119-1120. (doi:10.1111/apt.14351) (PMID:29105140)

Ijaz, U. Z. et al. (2017) The distinct features of microbial 'dysbiosis' of Crohn's disease do not occur to the same extent in their unaffected, genetically linked kindred. PLoS ONE, 12(2), e0172605. (doi:10.1371/journal.pone.0172605) (PMID:28222161) (PMCID:PMC5319678)

Svolos, V. et al. (2017) Dietary treatment of Crohn’s disease: perceptions of families with children treated by exclusive enteral nutrition, a questionnaire survey. BMC Gastroenterology, 17, 14. (doi:10.1186/s12876-016-0564-7) (PMID:28103809) (PMCID:PMC5247812)

Gerasimidis, K. , Ijaz, U. Z. , Edwards, C. , Russell, R. K., Quince, C. and Hansen, R. (2016) Response to Kaakoush et al. American Journal of Gastroenterology, 111(7), pp. 1033-1034. (doi:10.1038/ajg.2016.169) (PMID:27356826)

Quince, C. et al. (2015) Extensive modulation of the fecal metagenome in children with Crohn’s Disease during exclusive enteral nutrition. American Journal of Gastroenterology, 110, pp. 1718-1729. (doi:10.1038/ajg.2015.357) (PMID:26526081)

Hansen, R., Russell, R. K. and Muhammed, R. (2015) Recent advances in paediatric gastroenterology. Archives of Disease in Childhood, 100(9), pp. 886-890. (doi:10.1136/archdischild-2014-307089) (PMID:25710546)

Mukhopadhya, I., Hansen, R., Meharg, C., Thomson, J.M., Russell, R.K., Berry, S.H., El-Omar, E.M. and Hold, G.L. (2015) The fungal microbiota of de-novo paediatric inflammatory bowel disease. Microbes and Infection, 17(4), pp. 304-310. (doi:10.1016/j.micinf.2014.12.001) (PMID:25522934) (PMCID:PMC4392392)

Hansen, R., Scott, K. P., Khan, S., Martin, J. C., Berry, S. H., Stevenson, M., Okpapi, A., Munro, M. J. and Hold, G. L. (2015) First-pass meconium samples from healthy term vaginally-delivered neonates: an analysis of the microbiota. PLoS ONE, 10(7), e0133320. (doi:10.1371/journal.pone.0133320) (PMID:26218283) (PMCID:PMC4517813)

Adams, A. T. et al. (2014) Two-stage genome-wide methylation profiling in childhood-onset Crohnʼs disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflammatory Bowel Diseases, 20(10), pp. 1784-1793. (doi:10.1097/MIB.0000000000000179) (PMID:25144570)

Gerasimidis, K. , Russell, R., Hansen, R., Quince, C., Loman, N., Bertz, M., Hanske, L., Blaut, M., McGrogan, P. and Edwards, C. A. (2014) Role of Faecalibacterium prausnitzii in Crohnʼs Disease. Inflammatory Bowel Diseases, 20(7), E18-E19. (doi:10.1097/MIB.0000000000000079)

Hansen, R. et al. (2013) The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study. PLoS ONE, 8(3), e58825. (doi:10.1371/journal.pone.0058825) (PMID:23554935) (PMCID:PMC3595230)

Hansen, R. et al. (2012) Microbiota of de-novo pediatric IBD: increased faecalibacterium prausnitzii and reduced bacterial diversity in crohn's but not in ulcerative colitis. American Journal of Gastroenterology, 107(12), pp. 1913-1922. (doi:10.1038/ajg.2012.335)

Henderson, P. et al. (2012) Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflammatory Bowel Diseases, 18(6), pp. 999-1005. (doi:10.1002/ibd.21797) (PMID:21688352)

Mukhopadhya, I., Hansen, R., El-Omar, E. M. and Hold, G. L. (2012) IBD—what role do proteobacteria play? Nature Reviews Gastroenterology and Hepatology, 9(4), pp. 219-230. (doi:10.1038/nrgastro.2012.14) (PMID:22349170)

Hansen, R., Thomson, J. M., Fox, J. G., El-Omar, E. M. and Hold, G. L. (2011) Could Helicobacter organisms cause inflammatory bowel disease? FEMS Immunology and Medical Microbiology, 61(1), pp. 1-14. (doi:10.1111/j.1574-695X.2010.00744.x) (PMID:20955468)

Mukhopadhya, I. et al. (2011) A comprehensive evaluation of colonic mucosal isolates of sutterella wadsworthensis from inflammatory bowel disease. PLoS ONE, 6(10), e27076. (doi:10.1371/journal.pone.0027076)

Mukhopadhya, I., Thomson, J. M., Hansen, R., Berry, S. H., El-Omar, E. M. and Hold, G. L. (2011) Detection of campylobacter concisus and other campylobacter species in colonic biopsies from adults with ulcerative colitis. PLoS ONE, 6(6), e21490. (doi:10.1371/journal.pone.0021490) (PMID:21738679) (PMCID:PMC3124515)

Thomson, J. M. et al. (2011) Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities? PLoS ONE, 6(2), e17184. (doi:10.1371/journal.pone.0017184) (PMID:21383845) (PMCID:PMC3044171)

Hansen, R., Cameron, F. L., Hold, G. L., El-Omar, E. M. and Russell, R. K. (2010) Inflammatory bowel disease. Paediatrics and Child Health, 20(10), pp. 473-478. (doi:10.1016/j.paed.2010.04.005)

Conference or Workshop Item

Svolos, V. et al. (2017) Dietary Manipulation of the Healthy Human and Colitic Murine Gut Microbiome by CD-TREAT Diet and Exclusive Enteral Nutrition; A Proof of Concept Studyy. 12th Congress of ECCO, Barcelona, Spain, 15-18 Feb 2017. S29-S30. (doi:10.1093/ecco-jcc/jjx002.045)

Svolos, V., Hansen, R., Hughes, K., Ijaz, U.Z. , Quince, C., Gaya, D., Russell, R. and Gerasimidis, K. (2016) The Impact of ‘Crohn’s Disease-TReatment-with-EATing’ Diet (CD-TREAT Diet) and Exclusive Enteral Nutrition on Healthy Gut Bacteria Metabolism. 11th Congress of the European Crohn's and Colitis Organisation, Amsterdam, The Netherlands, 16-19 March 2016. S14-S15. (doi:10.1093/ecco-jcc/jjw019.017)

This list was generated on Tue Dec 10 02:55:17 2019 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • A pilot clinical trial to assess the clinical efficacy of the novel CD-TREAT
    Core
    2018 - 2020
     
  • The Imagekids study
    Glasgow Children`s Hospital Charity
    2018 - 2018
     
  • Dietary treatment of patients with inflammatory bowel disease
    Cure Crohn's Colitis
    2017 - 2018